Springer Nature

Corporate brand

Unclaimed Request correction

Global academic publisher with a branch in Shanghai, China.

Last updated October 2, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Springer Nature is a German-British academic publishing group headquartered in Berlin. It publishes and distributes scholarly research, professional information and educational content, with a particular emphasis on science, technology, medicine, the social sciences and related fields. Its portfolio includes the Nature family of journals and websites, Springer research journals and books, BMC open-access publishing, Palgrave Macmillan titles, SpringerLink and other digital products, as well as conference proceedings and educational materials. The company was created in May 2015 through the combination of Springer Science+Business Media with businesses owned by the Georg von Holtzbrinck Publishing Group, including Nature Publishing Group, Palgrave Macmillan and Macmillan Education. The merger brought together Springer-Verlag's long academic publishing history with Nature's high-profile scientific journal franchise and Macmillan's book and education operations. Holtzbrinck became the majority shareholder, while BC Partners remained an important investor through its ownership of the Springer business. Springer Nature operates a large international network of editors, reviewers, authors and institutional customers. Its main commercial relationships are with universities, research institutes, libraries, hospitals, learned societies, governments, companies and individual researchers. Revenue-generating activities include subscriptions and licensing for journals and databases, article-processing charges for open-access publication, sales of academic and professional books, advertising and partnership programs, and educational products and services. A defining strategic issue for the group has been the transition from print-led publishing to digital dissemination and open access. Springer Nature uses platforms such as Springer Nature Link and nature.com to provide online access, discovery tools, article metrics, alerts and research-support resources. It also promotes transformative and open-access agreements with libraries and institutions. The group competes in a concentrated scholarly publishing market with companies such as RELX, Wiley and Informa, while also working with the research community on peer review, research integrity, discoverability and reproducibility. The company pursued stock-market listings in 2018 and 2020, but both attempts were abandoned or postponed amid unfavorable market conditions. Springer Nature ultimately completed an initial public offering on the Frankfurt Stock Exchange on 4 October 2024. Shares were priced at €22.50, and the listing valued the company's equity at approximately €4.5 billion according to transaction advisers and reporting cited in the reference material. The business remains controlled through interests associated with Holtzbrinck and BC Partners-related funds. In 2021, it acquired Atlantis Press, strengthening its position in open-access scholarly publishing and conference proceedings. Today, Springer Nature's identity combines established publishing imprints with a large-scale digital research infrastructure. Its flagship Nature brand gives it unusually high visibility beyond the academic market, while Springer, BMC and Palgrave Macmillan provide breadth across disciplines, formats and access models.

History

Springer Nature's history is rooted in several major European and international publishing traditions. Julius Springer established Springer-Verlag in Berlin in 1842, creating the foundation for a scientific, technical and medical publishing business that later became Springer Science+Business Media. Separately, Macmillan Publishers was founded in 1843 and developed important book and education businesses. The journal Nature was launched in 1869 and became one of the world's best-known scientific publications. Nature Publishing Group later expanded the journal's reach through additional journals, digital services and scientific communications. During the late twentieth and early twenty-first centuries, these businesses were reorganized through ownership changes and acquisitions. Springer became associated with large-scale scientific, technical and medical journal and book publishing. The Holtzbrinck Publishing Group owned Nature Publishing Group, Palgrave Macmillan and Macmillan Education. These assets gave Holtzbrinck a broad presence in research communication, humanities and social-science publishing, and education. On 15 January 2015, the parties announced plans to combine Springer Science+Business Media with Holtzbrinck's Nature Publishing Group, Palgrave Macmillan and Macmillan Education operations. The transaction closed in May 2015, forming Springer Nature. Holtzbrinck held the majority stake, reported at 53%, while BC Partners continued to participate through the Springer ownership structure. The merger was intended to create a stronger global academic publisher able to invest in digital platforms, open access and large international journal and book programs. After the merger, Springer Nature expanded its role as both a content publisher and a research-information platform. SpringerLink and nature.com became important online destinations for journal articles, books, news and research tools. BMC contributed a substantial open-access publishing operation, while Springer and Palgrave Macmillan supplied extensive subscription, book and reference portfolios. The business also developed advertising, content-marketing and audience-partnership products aimed at researchers, clinicians, policymakers, industry audiences and science-interested consumers. The group faced recurring pressure from debt, changing library budgets, the growth of open access and difficult capital markets. It prepared an IPO in 2018, including plans to raise new capital and allow an investor sell-down, but the offering did not proceed. A second attempt was considered in 2020 and was also postponed amid market turbulence and the COVID-19 shock. In 2021, BC Partners increased or restructured its investment through a fund led by Neuberger Berman, while continuing to share ownership with Holtzbrinck-related interests. Springer Nature acquired Atlantis Press in 2021. The transaction added an open-access publisher founded in Paris in 2006, with particular relevance to scientific, technical and medical publishing and conference proceedings. This move was consistent with the group's broader development of open-access and digital-first services. The company returned to public markets in 2024. It completed an IPO on the Frankfurt Stock Exchange on 4 October, with shares priced at €22.50. The offering included newly issued equity and shares sold by an investment vehicle associated with BC Partners. The listing restored public-market access after the failed 2018 and 2020 attempts, while Holtzbrinck remained the largest shareholder. Springer Nature therefore entered its current phase as a publicly traded scholarly publisher with roots extending across more than 180 years of scientific, educational and book-publishing history.

2024
Springer Nature lists in Frankfurt
[2]Springer Nature shares leap on Frankfurt debutreuters.com
The company begins trading on the Frankfurt Stock Exchange at €22.50 per share.
2021
Atlantis Press is acquired
[1]Springer Natureen.wikipedia.org
Springer Nature adds the open-access publisher Atlantis Press and its scientific, technical, medical and conference-proceedings activities.
2018
First reported IPO attempt is abandoned
[6]First reported IPO attempt is abandonedreuters.com
The company prepares a Frankfurt listing intended to raise capital and reduce debt, but the offering does not proceed in the planned form.
2015
Springer Nature is formed
[1]Springer Natureen.wikipedia.org
Springer Science+Business Media merges with Nature Publishing Group, Palgrave Macmillan and Macmillan Education businesses owned by Holtzbrinck.
1869
Nature is launched
[1]Springer Natureen.wikipedia.org
The scientific journal Nature begins publication and later becomes the centerpiece of an influential scientific publishing and communications portfolio.
1842
Springer-Verlag is founded in Berlin
[1]Springer Natureen.wikipedia.org
Julius Springer establishes the publishing house that becomes the historical foundation of the Springer scientific and technical publishing business.

Products and positioning

A global, research-intensive scholarly publisher combining prestigious scientific journals, broad academic and professional content, open-access publishing and digital information services.

Scientific journals and science media · 1869
Nature
Nature is Springer Nature's best-known scientific publishing brand. Its portfolio includes the flagship Nature journal, specialist Nature research and review titles, and digital news, commentary and research-content services. The brand serves researchers across the life, physical and earth sciences and also reaches policymakers and the broader science-interested public. Its reputation is built on selective peer-reviewed research, influential reviews and high-profile scientific journalism.
Academic journals, books and digital research content · 1842
Springer
Springer publishes a wide range of journals, books, reference works, series and electronic resources across science, technology, medicine, business and the social sciences. Its catalog serves universities, laboratories, clinicians, engineers, students and professional researchers. Springer content is distributed through digital platforms as well as print and electronic book channels, and includes both subscription and open-access options.
Open-access journals
BMC
BMC is Springer Nature's open-access publishing portfolio, covering biomedical, health, life-science, physical-science and related disciplines. Its journals make articles freely available to readers, generally using article-processing charges or institutional arrangements to support publication. BMC is central to Springer Nature's transition toward open research and broader dissemination of scholarly results.
Digital research platform
SpringerLink
SpringerLink is the group's principal online platform for discovering and accessing Springer Nature journals, books, reference works and other scholarly materials. It supports institutional licensing, individual research use, searching, browsing and content delivery across a large international academic catalog.
Academic and professional books and journals
Palgrave Macmillan
Palgrave Macmillan publishes research monographs, textbooks, scholarly books, journals and professional content, particularly in the humanities, social sciences, business and related fields. The imprint complements Springer Nature's science and medical strengths with a substantial program aimed at scholars, students, libraries and professional readers.

Marketing campaigns

2019Springer Nature Media Options
Global
A partnership and advertising program used Nature, Springer and related digital and print properties to connect sponsors with researchers, clinicians, policymakers, industry leaders and science-interested audiences. Formats included display advertising, sponsored content, email and journal-alert placements.
Outcome. The program positioned Springer Nature's editorial brands and audience reach as a platform for scientific and healthcare marketing.
Source
Reaching the Right Scientific Audience
Global
A case-study campaign combined a Nature webcast for researchers, targeted journal content for clinicians and broader communication for science-engaged audiences. The approach segmented audiences across the research, healthcare and public-information continuum.
Outcome. The campaign model was designed to increase awareness of a partner's scientific product and communicate its development record to distinct professional audiences.
Source
Scientific and Clinical Audience Marketing
Global
Springer Nature offers digital advertising, clinical advertising, podcast, print, email and journal-alert products across Nature, Springer and BMC properties. The programs use contextual and audience-based targeting to reach scientific and healthcare professionals.
Outcome. These offerings extend the group's commercial role beyond publishing by providing targeted communication services around its research and medical content.
Source

Brand decisions

2024
Complete initial public offeringOther
Background
Earlier listing attempts in 2018 and 2020 did not reach completion, but improved market conditions enabled a later Frankfurt offering.
Action taken
Springer Nature issued new shares and BC Partners-related interests sold existing shares in an IPO on the Frankfurt Stock Exchange.
Aftermath
The company became publicly traded, with its equity valued at approximately €4.5 billion at the offer price.
Equity valuation at IPO. Approximately €4.5 billion (4 October 2024)
Source
2021
Acquire Atlantis PressM&A
Background
The acquisition supported Springer Nature's expansion in open-access scientific publishing and conference proceedings.
Action taken
Springer Nature acquired Atlantis Press, an open-access publisher founded in Paris in 2006.
Aftermath
Atlantis Press became part of the group's broader STM and open-access publishing activities.
Source
2015
Merge Springer Science+Business Media with Holtzbrinck science and education assetsM&A
Background
The combination was intended to create a larger international academic publisher with stronger digital scale and a broader portfolio spanning research, health, education and scholarly communications.
Action taken
The merger combined Springer with Nature Publishing Group, Palgrave Macmillan and Macmillan Education businesses.
Aftermath
Springer Nature became a major global scholarly publishing group controlled initially by a Holtzbrinck majority stake alongside BC Partners interests.
Source

Recent events

2024
Springer Nature completes Frankfurt initial public offering[2]Springer Nature shares leap on Frankfurt debutreuters.com
Other · Product launch
Springer Nature began trading on the Prime Standard of the Frankfurt Stock Exchange on 4 October 2024. The offer price was €22.50 per share, and the transaction valued the company's equity at approximately €4.5 billion.
2021
Springer Nature acquires Atlantis Press[1]Springer Natureen.wikipedia.org
M&A
The group acquired Atlantis Press, an open-access publisher focused on scientific, technical and medical content and conference proceedings.
2020
Springer Nature cancels or postpones earlier IPO plans[9]Springer Nature cancels or postpones earlier IPO plansreuters.com
Other
A planned Frankfurt listing was delayed as volatile markets and the coronavirus-related market disruption weakened the prospects for a large offering.

Sources13 sources

Cite this profile: Cite the canonical profile. /brand-wiki/springer-nature · Editorial policy · How profiles are compiled